General Statement of Disclosure:

EQUITY INTERESTS/STOCK OPTIONS: Rocket pharmaceuticals (SIGNIFICANT), Lexeo Therapeutics(SIGNIFICANT) OFFICER, DIRECTOR ETC: Lexeo Therapeutics (SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Papillon Therapeutics(MODEST)

View Full Disclosure